首页> 美国卫生研究院文献>European Journal of Human Genetics >γ-glutamyl transpeptidase deficiency caused by a large homozygous intragenic deletion in GGT1
【2h】

γ-glutamyl transpeptidase deficiency caused by a large homozygous intragenic deletion in GGT1

机译:由GGT1的大纯合基因内缺失引起的γ-谷氨酰转肽酶缺乏症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

γ-Glutamyl transpeptidase deficiency (glutathionuria, OMIM 231950) is a rare disease, with only six patients reported in the literature, although this condition has probably been underdiagnosed due the difficulty to routinely analyze glutathione in clinical samples and to the fact that no genetic defect has been coupled to the disease so far. We report two siblings with mild psychomotor developmental delay and mild neurological symptoms, who presented a markedly increased excretion of glutathione in urine and a very low γ-glutamyl transpeptidase activity in serum. Whole-genome sequencing revealed the presence of a 16.9 kb homozygous deletion in GGT1, one of the genes encoding enzymes with γ-glutamyl transpeptidase activity in the human genome. Close analysis revealed the presence of a 13 bp insertion at the deletion junction. This is the first report of a genetic variant as the cause of glutathionuria. In addition, genetic characterization of the patients’ parents and a healthy sibling has provided direct genetic evidence regarding the autosomal recessive nature of this disease.
机译:γ-谷氨酰转肽酶缺乏症(谷胱甘肽尿症,OMIM 231950)是一种罕见疾病,文献中仅报道了6例患者,尽管由于常规分析临床样本中的谷胱甘肽困难且无遗传缺陷这一事实,这种情况可能仍未得到充分诊断迄今为止,已与该疾病相关。我们报告了两个患有轻度精神运动发育迟缓和轻度神经系统症状的兄弟姐妹,他们表现出尿中谷胱甘肽的排泄显着增加,血清中的γ-谷氨酰转肽酶活性非常低。全基因组测序揭示了在人类基因组中编码具有γ-谷氨酰转肽酶活性的酶的基因之一GGT1中存在16.9kb的纯合缺失。仔细分析发现在缺失连接处存在13bp的插入。这是导致谷胱甘肽尿症的遗传变异的首次报道。此外,患者父母和同胞健康的遗传特征为这种疾病的常染色体隐性遗传提供了直接的遗传证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号